AG真人官方

Kineta, LLC (successor by merger to Kineta, Inc.) has filed Post-Effective Amendment No. 1 to nine Form S-8 registration statements to deregister all unsold shares that had been reserved for issuance under multiple legacy equity compensation and employee stock purchase plans of Proteostasis Therapeutics, Yumanity Therapeutics and Kineta.

The action follows the completion on 30 June 2025 of the two-step merger in which Kineta became a wholly-owned subsidiary of TuHURA Biosciences, Inc. (First Merger) and was subsequently merged into Hura Merger Sub II, LLC, which now operates as 鈥淜ineta, LLC.鈥� Because the merger terminated the underlying employee equity plans, the offerings contemplated by the affected S-8 statements have ended. In accordance with undertakings in each Form S-8, Kineta is formally removing from registration the remaining unissued shares.

Key details:

• 9 Form S-8 registration statements affected (Reg. Nos. 333-210521, 218544, 223664, 230155, 237181, 252691, 252692, 256853, 268969).
• Plans covered include Proteostasis 2008 & 2016 plans, ESPP, Yumanity 2018 & 2021 plans, and Kineta 2008, 2010, 2020 & 2022 plans.
• All remaining shares, including previously assumed awards (e.g., 908,205 option/RSU shares and 2,315,860 reserved shares under the Kineta 2022 EIP), are now deregistered.
• James A. Bianco, M.D., signed the amendment in Tampa, Florida on behalf of Kineta, LLC.

The filing is procedural, has no impact on current share-count reporting at TuHURA, and simply eliminates potential future dilution from the unsold shares.

LightWave Acquisition Corp. (Nasdaq: LWACU) has completed its special-purpose acquisition company (SPAC) initial public offering. The 8-K dated 30 June 2025 reports that on 26 June 2025 the company closed the sale of 21,562,500 units (including the full over-allotment option) at $10.00 per unit, generating $215.625 million in gross proceeds. Each unit contains one Class A ordinary share and one-half warrant exercisable at $11.50.

Simultaneously, the sponsor and BTIG purchased a total of 606,250 private-placement units at the same $10.00 price. Together, IPO and private-placement proceeds鈥�$215.625 million, inclusive of a $7.55 million deferred underwriting fee鈥攚ere deposited into a U.S.-based trust account managed by Continental Stock Transfer & Trust. The funds are restricted until (i) a business combination, (ii) redemption if no deal is completed within 24 months, or (iii) certain shareholder-approved amendments.

The filing also discloses execution of key agreements customary for SPACs, including the underwriting agreement (BTIG), warrant agreement, investment management trust agreement, registration-rights agreement, two private-placement purchase agreements, administrative-services agreement and indemnification agreements for officers and directors.

Corporate governance changes: Three independent directors鈥擱obert Hochberg (Audit Chair), Charlotte S. Blechman, and Allen C. Dickason (Compensation Chair)鈥攋oined the board on 24 June 2025. LightWave also adopted an amended & restated memorandum and articles of association with effect from the IPO closing.

Key takeaways for investors:

• Completed funding positions the SPAC with more than $215 million in trust to pursue an acquisition.
• Full exercise of the over-allotment option indicates solid demand for the offering.
• 24-month completion window and warrant structure introduce dilution and timeline risks typical of SPAC vehicles.

Perfect Moment Ltd. (NYSE American: PMNT) has filed a 424B5 prospectus supplement to sell 10,000,000 new common shares at $0.30 each, generating gross proceeds of $3.0 million and approximately $2.82 million in net proceeds before offering expenses. The issue price represents a 29% discount to the June 26, 2025 closing price of $0.424. The company has granted ThinkEquity a 45-day option to purchase up to 1,500,000 additional shares to cover over-allotments.

Concurrent with the closing, Joachim Gottschalk & Associates鈥攂eneficially owned by Chairman Max Gottschalk鈥攚ill convert a $507,808 promissory note (principal + interest) into 1,692,694 unregistered shares at the same $0.30 price under a Section 4(a)(2) exemption. This eliminates the related debt from the balance sheet.

Public float prior to the transaction was approximately $11.9 million (12,952,173 shares) based on a $0.92 high closing price within 60 days. The company confirms compliance with the baby-shelf limitation under General Instruction I.B.6 of Form S-3, noting no other securities have been sold under the shelf in the past 12 months.

Dilution impact: Existing outstanding shares total 19,391,000. The primary sale will raise the share count by 51% to 29.39 million; inclusion of the note conversion and full over-allotment could lift the total to about 32.58 million鈥攁n estimated 68% potential dilution to current holders.

The underwriting discount equals $0.018 per share (6%), plus a 1% non-accountable expense allowance. Shares are expected to be delivered on or about June 30, 2025.

Perfect Moment has filed a Form 424B5 prospectus supplement for an offering of common stock and pre-funded warrants. The company, trading under PMNT on NYSE American, is a luxury lifestyle brand specializing in ski wear, outerwear, swimwear, and activewear.

Key offering details:

• Offering common stock (price TBD) and pre-funded warrants with $0.0001 exercise price
• Current public float is approximately $11.9 million, based on 12,952,173 non-affiliate shares at $0.92 per share
• Concurrent debt conversion of $507,808 by Chairman Max Gottschalk's entity into common stock
• 45-day over-allotment option granted to underwriters
• ThinkEquity serving as underwriter

The company is limited by General Instruction I.B.6 of Form S-3, restricting them from selling more than one-third of their public float in any 12-month period while float remains below $75 million. The offering aims to support Perfect Moment's mission to become the leading luxury ski brand globally, combining fashion with technical performance.